Login

Marnix van Stiphout, COO of ING, discusses the impact of artificial intelligence and digitalization on the banking sector. 00:10:00

Share On Facebook Share On Twitter

Steven van Rijswijk, CEO of ING

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ricardo Carvalho Shares Insights on CBA’s Digital Transformation and Future Vision | Ricardo Carvalho, CEO , Companhia Brasileira de Alumínio.
00:10:00
Assessing Growth Trends and Investment Strategies | Bill Winters, CEO, Standard Chartered.
00:10:00
Impact Investing: Funding Social Outcomes Through Innovation
00:10:00
Understanding the Benefits and Considerations of Mechanically Stabilized Earth (MSE) Systems
00:10:00
"Dynamic Asset Allocation for Drawdown Protection: Des Lawrence of State Street Global Advisors on Leveraging the Market Regime Indicator for Strategic Investments"
00:10:00
Ajay Virmani, President and CEO of Cargojet, discusses how his company has successfully navigated challenges in an interview with Financial Post's Larysa Harapyn.
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Take Control with YourOwn Wallet | Nate Hoskin - Founder & Lead Advisor of Hoskin Capital
00:10:00
Eastern Metals’ Wayne Rossiter Highlights Success in Diamond Drilling at Browns Reef | Wayne Rossiter, CEO, Eastern Metals Ltd.
00:10:00
CEO OP Gulia on SVP Global Ventures’ Q1 FY22 Performance and Strategic Direction | OP Gulia, CFO, SVP Global Ventures Pvt Ltd.
00:10:00
Millicom CEO Mauricio Ramos presents the company's Child Online initiative on International Volunteer Day.
00:10:00
Joseph Jakavalley's Outlook on China's Electric Power Market

© 2026 Nehu